Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

NCT04853992 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT04853992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
Lead sponsor
JW Pharmaceutical
Phase
Phase 2
Overall status
Completed
Start date
May 10, 2021
Completion date
July 11, 2022
Enrollment
20 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cholinergic urticaria